Afficher la notice abrégée

dc.contributor.authorOsimani, Barbara
dc.date.accessioned2021-08-05T04:00:24Z
dc.date.available2021-08-05T04:00:24Z
dc.date.issued2020
dc.date.submitted2021-08-04T10:11:41Z
dc.identifierhttps://library.oapen.org/handle/20.500.12657/50312
dc.identifier.urihttps://directory.doabooks.org/handle/20.500.12854/71569
dc.description.abstractIn this paper I analyse the dissent around evidence standards in medicine and pharmacology as a result of distinct ways to address epistemic losses in our game with nature and the scientific ecosystem: an “elitist” and a “pluralist” approach. The former is focused on reliability as minimisation of random and systematic error, and is grounded on a categorical approach to causal assessment, whereas the latter is more focused on the high context-sensitivity of causation in medicine and in the soft sciences in general, and favours probabilistic approaches to scientific inference, as better equipped for defeasibility of causal inference in such domains. I then present a system for probabilistic causal assessment from heterogenous evidence that makes justice of concerns from both positions, while also incorporating “higher order evidence” (evidence/information about the evidence itself) in hypothesis confirmation.
dc.languageEnglish
dc.rightsopen access
dc.subject.otherUncertainty Management in Pharmacology, Causality,Medical Epistemology, evidence standards, random error, systematic error, extrapolation, relevance, bias
dc.subject.otherthema EDItEUR::M Medicine and Nursing::MK Medical specialties, branches of medicine::MKG Pharmacology
dc.titleChapter 15 Epistemic Gains and Epistemic Games
dc.title.alternativeReliability and Higher Order Evidence in Medicine and Pharmacology
dc.typechapter
oapen.identifier.doi10.1007/978-3-030-29179-2_15
oapen.relation.isPublishedBy9fa3421d-f917-4153-b9ab-fc337c396b5a
oapen.relation.isPartOfBookUncertainty in Pharmacology
oapen.relation.isPartOfBook09036601-8248-4c98-ae14-9dba24e8a578
oapen.relation.isFundedByH2020 European Research Council
oapen.relation.isFundedBy178e65b9-dd53-4922-b85c-0aaa74fce079
oapen.relation.isbn9783030291785
oapen.collectionEuropean Research Council (ERC)
oapen.pages28
oapen.grant.number639276
dc.relationisFundedBy178e65b9-dd53-4922-b85c-0aaa74fce079
dc.grantprojectPhilPharm


Fichier(s) constituant ce document

FichiersTailleFormatVue

Il n'y a pas de fichiers associés à ce document.

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée

open access
Excepté là où spécifié autrement, la license de ce document est décrite en tant que open access